Related Experiment Video
Updated: Jul 23, 2025

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Loss of PHF8 induces a viral mimicry response by activating endogenous retrotransposons
Yanan Liu1, Longmiao Hu1, Zhengzhen Wu1
1Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai, China.
Abstract:
Immunotherapy has become established as major treatment modality for multiple types of solid tumors, including colorectal cancer. Identifying novel immunotherapeutic targets to enhance anti-tumor immunity and sensitize current immune checkpoint blockade (ICB) in colorectal cancer is needed. Here we report the histone demethylase PHD finger protein 8 (PHF8, KDM7B), a Jumonji C domain-containing protein that erases repressive histone methyl marks, as an essential mediator of immune escape. Ablation the function of PHF8 abrogates tumor growth, activates anti-tumor immune memory, and augments sensitivity to ICB therapy in mouse models of colorectal cancer. Strikingly, tumor PHF8 deletion stimulates a viral mimicry response in colorectal cancer cells, where the depletion of key components of endogenous nucleic acid sensing diminishes PHF8 loss-meditated antiviral immune responses and anti-tumor effects in vivo. Mechanistically, PHF8 inhibition elicits H3K9me3-dependent retrotransposon activation by promoting proteasomal degradation of the H3K9 methyltransferase SETDB1 in a demethylase-independent manner. Moreover, PHF8 expression is anti-correlated with canonical immune signatures and antiviral immune responses in human colorectal adenocarcinoma. Overall, our study establishes PHF8 as an epigenetic checkpoint, and targeting PHF8 is a promising viral mimicry-inducing approach to enhance intrinsic anti-tumor immunity or to conquer immune resistance.
Insights
PHD finger protein 8 (PHF8) is a key driver of immune escape in colorectal cancer. Targeting PHF8 triggers a viral mimicry response, enhancing anti-tumor immunity and improving response to immune checkpoint blockade therapy.
Area of Science:
- Epigenetics
- Cancer Immunology
- Molecular Biology
Background:
- Immunotherapy, including immune checkpoint blockade (ICB), is a vital treatment for colorectal cancer.
- Novel therapeutic targets are needed to enhance anti-tumor immunity and overcome resistance to ICB.
- PHD finger protein 8 (PHF8) is a histone demethylase involved in epigenetic regulation.
Purpose of the Study:
- To investigate the role of PHF8 in colorectal cancer immune escape.
- To determine if targeting PHF8 can enhance anti-tumor immunity and ICB efficacy.
- To elucidate the mechanism by which PHF8 influences the tumor microenvironment.
Main Methods:
- Utilized mouse models of colorectal cancer with PHF8 ablation.
- Assessed tumor growth, anti-tumor immune memory, and response to ICB therapy.
- Investigated PHF8's impact on viral mimicry, nucleic acid sensing pathways, and epigenetic modifications (H3K9me3, SETDB1).
- Analyzed PHF8 expression in human colorectal adenocarcinoma tissues.
Main Results:
- PHF8 ablation significantly inhibited tumor growth and activated anti-tumor immune memory in mouse models.
- PHF8 deletion induced a viral mimicry response, increasing sensitivity to ICB therapy.
- PHF8 inhibition led to H3K9me3-dependent retrotransposon activation via SETDB1 degradation.
- PHF8 expression inversely correlated with immune signatures and antiviral responses in human colorectal cancer.
Conclusions:
- PHF8 acts as an epigenetic checkpoint mediating immune escape in colorectal cancer.
- Targeting PHF8 represents a promising strategy to induce viral mimicry, boost intrinsic anti-tumor immunity, and overcome ICB resistance.
More Related Videos
Related Concept Videos
Retroviruses
Non-LTR Retrotransposons
Retrovirus Life Cycles
Viruses with RNA Genomes
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Mechanisms of Retrovirus-induced Cancers

